Culture-positive COVID-19-associated pulmonary aspergillosis (CAPA) in Germany
Our data reveal regional differences in prevalence, diagnosis, and treatment of culture-positive CAPA in Germany. We could identify new factors affecting survival or mortality.
Authors
- Tamara Ruegamer (ORCID: https://orcid.org/0000-0002-1535-8625)
- Ronny Martin (ORCID: https://orcid.org/0000-0002-2212-1511)
- Joerg Steinmann (ORCID: https://orcid.org/0000-0002-3181-3667)
- Oliver Kurzai (ORCID: https://orcid.org/0000-0002-7277-2646)
- Nadja Thielemann (ORCID: https://orcid.org/0000-0002-3540-1547)
- Alexander Maximilian Aldejohann (ORCID: https://orcid.org/0000-0001-7246-5518)
- Grit Walther (ORCID: https://orcid.org/0000-0003-4030-4618)
- Leonie H Aldejohann
Institutions
- University of Würzburg (DE)
- University Hospital Regensburg (DE)
- Paracelsus Medizinische Privatuniversität (DE)
- Institute of Medical Microbiology and Hygiene (DE)
- University Hospital Cologne (DE)
- Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) (DE)
Publication Details
- Journal
- International Journal of Medical Microbiology
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1016/j.ijmm.2025.151676
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00